GILD in the 13F filings
Gilead Sciences Inc · CUSIP 375558103
- Quarter end
- 31 Mar 2024
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 10 May 2024
- Managers listing it
- 30
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q4 2023 and Q1 2024; 22 listed it in both
- Shares listed
- 276,966,839
- combined, among listed positions
- Reported value
- $20.3bn
- combined, at the quarter end
Among the 93 comparable managers: 17 buyers (opened or added shares) and 12 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing GILD in Q1 2024
30 of 30 holders
Largest increases and reductions, by shares
Increases
- Two Sigma Advisers LPexisting position · 5,079,600 shares now+3,910,300
- Voloridge Investment Management LLCnew position · 3,510,139 shares now+3,510,139
- Wellington Management Group LLPexisting position · 20,567,752 shares now+1,937,618
- Capital Research Global Investorsexisting position · 61,246,366 shares now+1,589,240
- Capital World Investorsexisting position · 84,497,404 shares now+1,133,281
Reductions
- Neuberger Berman Group LLCexisting position · 964,683 shares now-4,599,385
- Arrowstreet Capital LPexisting position · 5,046,433 shares now-3,331,941
- Renaissance Technologies LLCexisting position · 4,317,650 shares now-1,258,200
- AQR Capital Management LLCexisting position · 3,314,704 shares now-549,472
- Woodline Partners LPexisting position · 1,000,779 shares now-463,362
New positions and exits
New (4)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 22 | $26.4bn | n.a. | n.a. |
| Q3 2013 | 20 | $31.7bn | n.a. | n.a. |
| Q4 2013 | 24 | $35.6bn | n.a. | n.a. |
| Q1 2014 | 26 | $30.7bn | n.a. | n.a. |
| Q2 2014 | 26 | $35.5bn | n.a. | n.a. |
| Q3 2014 | 28 | $40.8bn | n.a. | n.a. |
| Q4 2014 | 30 | $30.9bn | n.a. | n.a. |
| Q1 2015 | 32 | $31.9bn | n.a. | n.a. |
| Q2 2015 | 31 | $36.4bn | n.a. | n.a. |
| Q3 2015 | 31 | $27.6bn | n.a. | n.a. |
| Q4 2015 | 34 | $25.0bn | n.a. | n.a. |
| Q1 2016 | 35 | $18.5bn | n.a. | n.a. |
| Q2 2016 | 33 | $15.5bn | n.a. | n.a. |
| Q3 2016 | 30 | $12.9bn | n.a. | n.a. |
| Q4 2016 | 33 | $11.4bn | n.a. | n.a. |
| Q1 2017 | 33 | $9.9bn | n.a. | n.a. |
| Q2 2017 | 33 | $10.4bn | n.a. | n.a. |
| Q3 2017 | 27 | $12.4bn | n.a. | n.a. |
| Q4 2017 | 28 | $12.3bn | n.a. | n.a. |
| Q1 2018 | 32 | $14.0bn | n.a. | n.a. |
| Q2 2018 | 29 | $13.6bn | n.a. | n.a. |
| Q3 2018 | 29 | $15.6bn | n.a. | n.a. |
| Q4 2018 | 32 | $13.3bn | n.a. | n.a. |
| Q1 2019 | 32 | $14.9bn | n.a. | n.a. |
| Q2 2019 | 29 | $16.1bn | n.a. | n.a. |
| Q3 2019 | 30 | $13.9bn | n.a. | n.a. |
| Q4 2019 | 32 | $14.3bn | n.a. | n.a. |
| Q1 2020 | 28 | $17.0bn | n.a. | n.a. |
| Q2 2020 | 23 | $18.7bn | n.a. | n.a. |
| Q3 2020 | 25 | $14.2bn | n.a. | n.a. |
| Q4 2020 | 27 | $13.4bn | n.a. | n.a. |
| Q1 2021 | 24 | $14.5bn | n.a. | n.a. |
| Q2 2021 | 18 | $14.9bn | n.a. | n.a. |
| Q3 2021 | 20 | $16.4bn | n.a. | n.a. |
| Q4 2021 | 20 | $16.8bn | n.a. | n.a. |
| Q1 2022 | 28 | $13.2bn | n.a. | n.a. |
| Q2 2022 | 26 | $13.6bn | n.a. | n.a. |
| Q3 2022 | 24 | $13.3bn | n.a. | n.a. |
| Q4 2022 | 32 | $21.1bn | n.a. | n.a. |
| Q1 2023 | 27 | $21.8bn | n.a. | n.a. |
| Q2 2023 | 24 | $20.7bn | n.a. | n.a. |
| Q3 2023 | 24 | $20.0bn | n.a. | n.a. |
| Q4 2023 | 22 | $21.5bn | 10 | 11 |
| Q1 2024 | 30 | $20.3bn | 17 | 12 |
| Q2 2024 | 28 | $18.5bn | 15 | 14 |
| Q3 2024 | 29 | $24.2bn | 15 | 15 |
| Q4 2024 | 28 | $25.9bn | 14 | 14 |
| Q1 2025 | 33 | $32.0bn | 21 | 12 |
| Q2 2025 | 27 | $30.9bn | 18 | 10 |
| Q3 2025 | 23 | $29.4bn | 9 | 14 |
| Q4 2025 | 25 | $34.3bn | 18 | 19 |
| Q1 2026 | 25 | $38.5bn | 16 | 21 |
| Q2 2026 | 26 | $34.2bn | 22 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GILD and AMGN →GILD and ARGX →GILD and RVMD →Choose a stock to compare with GILD →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GILD, latest filings →Back to the 13F Explorer →